Calyxt, Inc. Announces the Appointment of Seth Dobrin to the Company's Scientific Advisory Board
October 12, 2021 at 12:00 pm
Share
Calyxt, Inc. announced the appointment of Seth Dobrin to the Company's Scientific Advisory Board (SAB). Dr. Dobrin is the Global Chief Artificial Intelligence (AI) Officer at IBM and brings extensive leadership experience and a track record of transforming companies through data and AI. In his role at IBM, Dr. Dobrin leads the corporate AI strategy. He is responsible for connecting AI development with a systemic creation of business value via a design-driven strategy that enables a transformation of IBM's core operations. Dr. Dobrin leads the effort to fundamentally change every area of IBM, from business operations to product development, by adopting a human-centered approach to AI through a new methodology that he created that ensures continuous and responsible delivery of AI-based business outcomes across the company.
Cibus, Inc. is an agricultural technology company that uses gene editing technologies to develop plant traits in seeds. Its business is the development of plant traits that help address specific productivity or yield challenges in farming, such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate. It is also engaged in developing, certain alternative plant-based oils or bio-based fermentation products. Its technology is its gene editing platform called the Rapid Trait Development System (RTDS). It is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. It has a pipeline of five productivity traits, four of which are applicable to multiple crops. These traits are PSR in Canola and HT1 and HT3 in rice. In addition, it also has two advanced traits for Sclerotinia resistance and another novel broadleaf HT trait, HT2.
CALYXTPAR 
